RT Journal Article
SR Electronic
T1 Resonance sonomanometry for noninvasive, continuous monitoring of blood pressure
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.24.23300502
DO 10.1101/2023.12.24.23300502
A1 Jimenez, Raymond
A1 Yurk, Dominic
A1 Dell, Steven
A1 Rutledge, Austin C.
A1 Fu, Matt K.
A1 Dempsey, William P.
A1 Abu-Mostafa, Yaser
A1 Rajagopal, Aditya
A1 Rajagopal, Alaina Brinley
YR 2023
UL http://medrxiv.org/content/early/2023/12/28/2023.12.24.23300502.abstract
AB Cardiovascular disease is the leading cause of death worldwide. Existing methods for continuous, noninvasive blood pressure monitoring suffer from poor accuracy, uncomfortable form factors, or a need for frequent calibration, limiting their adoption. We introduce a new framework for continuous BP measurement that is noninvasive and calibration-free. The method uses acoustic stimulation to induce resonance of the artery wall. Ultrasound imaging is used to measure resonance and capture arterial dimensions which are related to blood pressure via a fully-determined physical model. The approach and model are validated in vitro using arterial mock-ups and then in multiple arteries in human subjects. Further development could facilitate more robust continuous blood pressure measurement, providing significant benefits for early diagnosis and treatment of cardiovascular disease.Competing Interest StatementAll authors have varying equity and interest (e.g., current or former employment) in Esperto Medical, the company which sponsored the research and study. Several authors (A.R., A.B.R., D.Y., Y.A., R.J.) are listed as inventors on patents which cover material in this manuscript.Funding StatementThis research was funded by Esperto Medical, Inc. The authors are also grateful to Charlie Trimble, the Carver Mead Innovation Fund, the Grubstake Grant, Maverick Capital, and the California Institute of Technology for funding and research which made this work possible.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the California Institute of Technology gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.